Patterns of early and late recurrence across breast cancer subtypes in the CCTGMA.32 trial. Extended endocrine therapy after 5 years of adjuvant LHRH-agonist in premenopausal patients with ...
Analysis of a pre-screening platform for clinical trials in patients with prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full ...
Cato Networks this week announced a new policy analysis engine for its cloud-based secure access service edge platform that the company says will optimize and improve SASE policies, reduce risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback